Allelic imbalance at chromosome 1q21 in Wilms tumor

Cancer Genetics and Cytogenetics

Volumn 97, Issue 1, 1997, Pages 54-59

  Law, Megan H ^a   Algar, Elizabeth ^a,b   Little, Melissa ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 1Q; CHROMOSOME TRANSLOCATION 1; COSMID; CYTOGENETICS; GENE MAPPING; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; NEPHROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TARGET CELL;

ALLELES; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 1; GENES, WILMS TUMOR; HUMANS; KARYOTYPING; KIDNEY NEOPLASMS; MICROSATELLITE REPEATS; TRISOMY; WILMS TUMOR;

EID: 0031214256     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00342-1     Document Type: Article

References (39)

1. 1. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990): Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520.
2. 2. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA (1990): Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778.
3. 3. Little M, Wells C (in press): A clinical overview of WT1 gene mutations. Hum Mut.
4. 4. Reeve AE, Sih SA, Raizis AM, Feinberg AP (1989): Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol 9:1799-1803.
5. 5. Radice P, Perotti D, De Benedetti V, Mondini P, Radice MT, Pilotti S, Luksch R, Bellani FF, Pierotti MA (1995): Allcotyping in Wilms' tumours identifies a putative third tumour suppressor gene on chromosome 11. Genomics 27:497-501.
6. 6. Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC (1994): Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 54:2331-2333.
7. 7. Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE, Callen DF, Thompson AD, Richards RI, Reeve AE (1992): A third Wilms' tumor locus on chromosome 16q. Cancer Res 52: 3094-3098.
8. 8. Slater RM, Mannens MM (1992): Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet Cytogenet 61:111-121.
9. 9. Solis V, Pritchard J, Cowell JK (1988): Cytogenetic changes in Wilms' tumors. Cancer Genet Cytogenet 34:223-234.
10. 10. Wang-Wuu S, Soukup SBK, Gotwals B, Lampkin B (1990): Chromosome analysis of 31 Wilms' tumors. Cancer Res 50: 2786-2793.
11. 11. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE (1991): Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc Natl Acad Sci USA 88:9618-9622.
12. 12. Rauscher FI (1994): The WT1 Wilms' tumor gene product: A developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J 7:896-903.
13. 13. Drummond IA, Rupprecht HD, Rohwer NP, Lopez GJ, Madden SL, Rauscher Fr, Sukhatme VP (1994): DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol Cell Biol 14:3800-3809.
14. 14. Rupprecht HD, Drummond IA, Madden SL, Rauscher FI, Sukhatme VP (1994): The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 269:6198-6206.
15. 15. Bickmore WA, Oghene K, Little MH, Seawright A, van Heyningen V, Hastie ND (1992): Modulation of DNA binding specificity by alternative splicing of the Wilms' tumor WT1 gene transcript. Science 257:235-237.
16. 16. Little MH, Holmes G, Pell L, Duarte A, Law M, Caricasole A, Ward A, Wainwright B (1996): A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers. Oncogene 13:1461-1469.
17. 17. Negus K, Holmes G, Wicking K, Wainwright B, Little M (1996): +P5, a novel target binding site for the Wilms' tumour suppressor 1 (WT1) gene, maps to human chromosome 1 band q21-22. Cytogenet Cell Genet 72:305-309.
18. 18. Little MH, Dunn R, Byrne JA, Seawright A, Smith PJ, Pritchard-Jones K, van Heyningen V, Hastie ND (1992): Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal and Wilms' tumours. Oncogene 7:635-641.
19. 19. Algar EM, Kenney M, Simms L, Smith S, Kida Y, Smith PJ (1995): Homozygous intragenic deletion in the WT1 gene in a sporadic: Wilms' tumour with high levels of expression of a truncated transcript. Hum Mut 5:221-227.
20. 20. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M (1992): A second-generation linkage map of the human genome. Nature 359:794-801.
21. 21. Engelstein M, Hudson TJ, Lane LM, Lee MK, Leverone B, Landes GM, Peltonen L, Weber JL, Dracopoli NC (1993): A PCR-based linkage map of human chromosome 1. Genomics 15:251-258.
22. 22. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994): The 1993-94 Genethon human genetic linkage map. Nature Genet 7:246-255.
23. 23. Little MH, Prosser J, Condie A, Smith PJ, van Heyningen V, Hastie ND (1992): Zinc; finger point mutations within the WT1 gene in Wilms' tumor patients. Proc Natl Acad Sci USA 89:4791-4795.
24. 24. Khosla S, Patel VM, Schaid DJ, Grant CS, van Heerden JA, Thibobeau SN (1991): Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest 87:1691-1699.
25. 25. Cryns VL, Yi SM, Tahara H, Gaz, RD, Arnold A (1995): Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosom Cancer 13:9-17.
26. 26. Bieche I, Champeme MH, Lidereau R (1995): Loss and gain of distinct regions of chromosome 1q in primary breast cancer. Clin Cancer Res 1:123-127.
27. 27. Devilee P, van den Broek M, Mannens M, Slater R, Cornelisse CJ, Westerveld A, Khan PM (1991): Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumours of childhood. Int J Cancer 47:817-821.
28. 28. Atkins NB (1986): Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet 21:279-285.
29. 29. Chen LC, Dollbaum C, Smith HS (1989): Loss of heterozygosity on chromosome 1q in human breast cancer. Proc Natl Acad Sci U S A 86:7204-7207.
30. 30. Loupart ML, Armour J, Walker R, Adams S, Brammer W, Varley J (1995): Allelic imbalance on chromosome 1 in human breast cancer. 1. Minisatellite and RFLP analysis. Genes Chromosom Cancer 12:16-23.
31. 31. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y, Kajiyama G, Tahara E (1991): Frequent loss of heterozygosity on chromosomes 1q, 5q and 17p in human gastric carcinomas. Cancer Res 51:2926-2931.
32. 32. Bare JW, Lebo RV, Epstein EH (1992): Loss of heterozygosity at chromosome 1q22 in basal cell carcinomas and exclusion of the basal cell nevus syndrome from this site. Cancer Res 52:1494-1498.
33. 33. Whang-Peng J, Knutsen T, Jaffe ES, Steinberg SM, Raffeld R, Zhoa WP, Duffey P, Condron P, Yano, Longo DL (1995): Sequential analysis of 43 patients with non-Hodgkin's lymphoma: Clinical correlations with cytogenetic, histologic, immunphenotyping and molecular studies. Blood 85:203-216.
34. 34. Craig RW, Wang Jabs E, Zhou P, Kozopas KM, Hawkins AL, Rochelle JM, Seldin, MF, Griffin CA (1994): Human and mouse chromosomal mapping of the myeloid cell leukemia-1 gene: MCL1 maps to human chromosome 1q21, a region that is frequently altered in preneoplastic and neoplastic disease. Genomics 23:457-463.
35. 35. Kwong YL (1995): Constitutional duplication 1q in acute myeloid leukemia. Cancer Genet Cytogenet 80:82.
36. 36. Yunis JJ, Soreng AL (1984): Constitutive fragile sites and cancer. Science 226:1199-1204.
37. 37. DiPaolo JA, Popescu NG, Alvarez, L, Woodworth CD (1993): Cellular and molecular alterations in human epithelial cells transformed by reeombinant human papillomavirus DNA. Crit Rev Oncol 4:337-360.
38. 38. Fundia A, Gorla N, Larripa L (1994): Spontaneous chromosome aberrations in Fanconi's anemia patients are located at fragile sites and acute myeloid leukemia breakpoints. Hereditas 120:47-50.
39. 39. King-Underwood L, Renshaw J, Pritchard-Jones K (1996): Mutations in the Wilms' tumour gene WT1 in leukemias. Blood 87:2171-2179.